About:
Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of Class I and II HDAC, as...
its seems as if most big spikers have been showing this pattern of day one gapping up then dropping to consolidating establishing support then day 2 morning panic bouncing off day one support then consolidating then breaking day two bounce spike to consolidating finishing strong and then running further on day 3 for anotherspikehttps://www.tradingview.com/x/AIrIiSrQ/
CRIS has formed multiple bottoms on the day chart. But if you switch the settings so each candle represents a month, you will see that it has formed multiple bottoms as well. This seems to be a good gamble play stock. at this level, it looks like it could be worth a few bucks. keep on your watch list.
Are you into scalping?, if yes then PA is at a great retracment time on Fib Ret to see what happens with a couple of thousand shares? Price action is at an all time low ( is there any CATALYSIS) for this stock to rocket up? Please check future if you are into scalping or even holding to...lets a $1.00.
NASDAQ:CRIS Trade details on chart. This trade should not take more than 1-2 hours to distinguish itself as a winner or loser. Either the trend and supports will hold early, or they should fail early, allowing you to move along without spending an entire day waiting to see if this is a trade you should make. Good luck to all.
Just wanted to post this idea to put this company on people's watchlist. It is clearly in a downtrend, and earnings dropped it to lows with no clear resistance; however, after the drop there was big insider buying (something there hasn't been in the company), so I take it as a very good sign. I will be watching closely to see if the trend turns around.
looks like bullflag continuation to me volume confirmation breaking the kumo senkou line. head and shoulder reversal is done big bounce off support should go higher
CRIS has broken the daily downtrend with a strong impulse. I'm looking for a pullback, one more wave up and a big drop. Look to the price action for more details.
if the price breaks 1.83 could go easly to 2...what I dont like is the choppy price acion before and the SMA200 at 1.92, lets see if we have power on the volume
Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of Class I and II HDAC, as well as Class I PI3K enzymes. CA-170 is an oral small molecule drug candidate that is designed to selectively target programmed death ligand-1 (PDL1) and V-domain Ig suppressor of T-cell activation (VISTA) immune checkpoint proteins, both of which independently function as negative regulators of immune activation. CA-4948 is an oral small molecule drug candidate that is designed to inhibit the Interleukin-1 receptor-associated kinase 4 (IRAK4) kinase, which is a transducer of toll-like receptor or certain interleukin receptor signaling pathways.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
CRIS
